Joshua Silverman Synaptogenix, Inc. (SNPX) insider trading activity

Joshua Silverman is Executive Chairman of Synaptogenix, Inc.. Currently has a direct ownership of 86,681 shares of SNPX, which is worth approximately $565,160. The most recent transaction as insider was on Oct 17, 2025, when has been sold 40,000 shares (Common Stock, par value $0.0001 per share) at a price of $7.23 per share, resulting in proceeds of $289,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 86.7K

224.88% 3M change

126.69% 12M change

Total Value Held $565,160

Joshua Silverman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 17 2025	SELL Payment of exercise price or tax liability	$289,200 $7.23 p/Share	40,000 Reduced 31.58%	86,681 Common Stock, par valu...
Oct 17 2025	BUY Grant, award, or other acquisition	-	100,000 Added 44.11%	126,681 Common Stock, par valu...
Jun 30 2025	SELL Payment of exercise price or tax liability	$131,628 $7.85 p/Share	16,768 Reduced 38.59%	26,681 Common Stock, par valu...
Jun 30 2025	BUY Grant, award, or other acquisition	-	41,919 Added 49.1%	43,449 Common Stock, par valu...
Dec 16 2022	SELL Open market or private sale	$22,244 $1.17 p/Share	19,012 Reduced 33.21%	38,238 Common Stock, par valu...
Jul 13 2021	BUY Grant, award, or other acquisition	-	90,000 Added 46.15%	105,000 Common Stock, par valu...
Jun 14 2021	BUY Open market or private purchase	$83,000 $8.3 p/Share	10,000 Added 40.0%	15,000 Common Stock, par valu...

Also insider at

AYRO

AYRO, Inc. Consumer Cyclical

Chief Executive Officer

PTPI

Petros Pharmaceuticals, Inc. Healthcare

Director

MYMD

MyMD Pharmaceuticals, Inc. Healthcare

Executive Chairman

FEMY

FEMASYS INC Healthcare

PMCB

PharmaCyte Biotech, Inc. Healthcare

CEO and President